1480 related articles for article (PubMed ID: 6152157)
1. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: Bronchodilating effect.
Murai T; Maejima T; Sanai K; Osada E
Arzneimittelforschung; 1984; 34(11A):1633-40. PubMed ID: 6152156
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. III: Effects on the central nervous system, striated muscle and carbohydrate and lipid metabolism.
Osada E; Sakaya S; Sanai K; Seri K
Arzneimittelforschung; 1984; 34(11A):1652-8. PubMed ID: 6152158
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies of mabuterol, a new selective beta 2-stimulant. II: Urinary metabolites of mabuterol in rats and their pharmacological effects.
Horiba M; Murai T; Nomura K; Yuge T; Sanai K; Osada E
Arzneimittelforschung; 1984; 34(11A):1668-79. PubMed ID: 6152160
[TBL] [Abstract][Full Text] [Related]
5. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
Engelhardt G
Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.
Kato H; Nakayama K; Takata Y; Kurihara J; Sakai T; Iwata K; Yamamoto I
Arzneimittelforschung; 1985; 35(7):1037-41. PubMed ID: 4052137
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
8. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
9. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
10. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
Brittain RT; Levy GP
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
[TBL] [Abstract][Full Text] [Related]
11. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
12. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
Akahane K; Furukawa Y; Ogiwara Y; Haniuda M; Chiba S
Br J Pharmacol; 1989 Jul; 97(3):709-16. PubMed ID: 2474351
[TBL] [Abstract][Full Text] [Related]
14. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
[TBL] [Abstract][Full Text] [Related]
15. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
16. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
Lindner E
Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.
Ikeo T; Nagao T; Murata S; Yabana H; Sato M; Nakajima H
Arzneimittelforschung; 1986 Jul; 36(7):1063-8. PubMed ID: 3768073
[TBL] [Abstract][Full Text] [Related]
19. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
